Frank Holms
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 5
- Cancer Cells and Metastasis 3
- Cancer Treatment and Pharmacology 2
-
- Breast Cancer Treatment Studies 9
- Cancer Genomics and Diagnostics 2
- Co-authors
- Hans Tesch (9 shared papers)Sibylle Loibl (10 shared papers)Michael Untch (9 shared papers)Gϋnter von Minckwitz (7 shared papers)Jens Huober (6 shared papers)Tanja Fehm (5 shared papers)Iris Schrader (6 shared papers)Klaus Pantel (3 shared papers)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (2 papers)Breast Cancer Research and Treatment (1 paper)Breast Care (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Frank Holms
11 papers receiving 589 citations
Peers
Comparison fields: 5 of 36
- Cancer Research 324
- Oncology 481
- Pulmonary and Respiratory Medicine 83
- Radiology, Nuclear Medicine and Imaging 39
- Biomedical Engineering 82
Countries citing papers authored by Frank Holms
This map shows the geographic impact of Frank Holms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Holms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Holms more than expected).
Fields of papers citing papers by Frank Holms
This network shows the impact of papers produced by Frank Holms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Holms. The network helps show where Frank Holms may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Holms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 402 | |
| 2 | 2017 | 86 | |
| 3 | 2011 | 38 | |
| 4 | 2011 | 35 | |
| 5 | 2011 | 11 | |
| 6 | 2010 | 10 | |
| 7 | 2010 | 8 | |
| 8 | 2017 | 5 | |
| 9 | 2011 | 2 | |
| 10 | 2011 | 2 | |
| 11 | 2019 | 1 |
About Frank Holms
Frank Holms is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Neurology, having authored 11 papers that have together received 600 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Cells and Metastasis (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Treatment and Pharmacology (2 papers), Advanced Breast Cancer Therapies (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Cancer Research (324 citations), Oncology (481 citations), Pulmonary and Respiratory Medicine (83 citations), Radiology, Nuclear Medicine and Imaging (39 citations) and Biomedical Engineering (82 citations). Frank Holms has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Hans Tesch, Sibylle Loibl, Michael Untch, Gϋnter von Minckwitz, Jens Huober, Tanja Fehm, Iris Schrader, Klaus Pantel, Volkmar Müller and Sabine Riethdorf. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Breast Cancer Research and Treatment and Breast Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.